Image-guided percutaneous biopsies are increasingly preferred to surgical biopsies. This technique rarely misses breast cancers (0???%), and correlation of clinical, imaging, and histological findings usually identify lesions requiring re-biopsy quickly. Communication of results to patients requires that the implications of the findings and their bearing on management are explained. Society is increasingly passing responsibility for ensuring follow-up to clinicians.
Get full access to this article
View all access options for this article.
References
1.
LibermanL.Percutaneous imaging guided core breast biopsy: state of the art at the millennium. Am J Roentgenol 2000; 174:1191?.
2.
LeeCHLEPhilpottsHorvathLJ Follow up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: frequency of mammographic change and false negative rate. Radiol 1999; 212:189?4.
3.
David D Dershaw (editor). Imaging-guided interventional breast techniques. New York: Springer-Verlag; 2003.
4.
Bassett L,Winchester DP,Caplan RB Stereotactic core-needle of the breast: a report of the joint task force of the American College of Radiology,American College of Surgeons and College of American Pathologists. CA Cancer J Clin 1997;47:171?90 http://caonline.amcancersoc.org/cgi/reprint/47/3/171.
5.
BerlinL.Tracking for breast cancer (commentary). Am J Roentgenol 1998; 170:93?.
